{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:12:32Z","timestamp":1764493952366},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human papillomavirus infection plays a key role in the development of cervical cancer. To establish a foundation for HPV-based screening and vaccination programs, we investigated the HPV prevalence and genotypic distributions in Chinese women from Zhejiang Province. Between 2011 and 2015, a total of 961,029 samples from 2021 clinical hospitals were tested HPV genotype by a PCR-based hybridization gene chip assay, and 443,890 samples were evaluated cervical cytology by liquid-based cytology analysis. Our results showed that the positive rate for HPV was 20.54%, which ranged from 28.72% to 17.81% and varied by year of recruitment. Age-specific prevalence showed a \u201ctwo-peak\u201d pattern, with the \u226420-year-old group presenting the highest HPV infection rate, followed by 61\u201370-year-old group. Overall, the most prevalent genotypes were HPV16, 52 and 58. Additionally, the odds ratios for the prevalence of the HR-HPV, LR-HPV and HPV-negative groups with abnormal cytology were 12.56, 3.21 and 0.06, respectively. Among genotypes, HPV 16 has been found to have the highest OR, followed by HPV58, 18, 52. Here, we present data regarding the prevalence and type distribution of HPV infection, which can serve as valuable reference to guide nationwide cervical cancer screening and HPV vaccination programs.<\/jats:p>","DOI":"10.1038\/s41598-017-13299-y","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T11:33:03Z","timestamp":1509017583000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015"],"prefix":"10.1038","volume":"7","author":[{"given":"Xiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanwan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"13299_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin \n                           65, 87 (2015).","journal-title":"CA Cancer J Clin"},{"key":"13299_CR2","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2009.20.2.72","volume":"20","author":"K Kim","year":"2009","unstructured":"Kim, K., Zang, R., Choi, S. C., Ryu, S. Y. & Kim, J. W. Current status of gynecological cancer in China. J Gynecol Oncol\u00a020, 72 (2009).","journal-title":"J Gynecol Oncol"},{"key":"13299_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz, N. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med \n                           348, 518 (2003).","journal-title":"N Engl J Med"},{"key":"13299_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.24.3106","volume":"286","author":"NF Schlecht","year":"2001","unstructured":"Schlecht, N. F. et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA \n                           286, 3106 (2001).","journal-title":"JAMA"},{"key":"13299_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/488S2a","volume":"488","author":"JM Crow","year":"2012","unstructured":"Crow, J. M. HPV: The global burden. Nature \n                           488, S2 (2012).","journal-title":"Nature"},{"key":"13299_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70256-4","volume":"11","author":"FH Zhao","year":"2010","unstructured":"Zhao, F. H. et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol\u00a011, 1160 (2010).","journal-title":"Lancet Oncol"},{"key":"13299_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn510","volume":"101","author":"CM Wheeler","year":"2009","unstructured":"Wheeler, C. M. et al. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst \n                           101, 475 (2009).","journal-title":"J Natl Cancer Inst"},{"key":"13299_CR8","volume":"12","author":"CY Chan","year":"2011","unstructured":"Chan, C. Y. et al. A qualitative study on HPV vaccination from a nursing perspective in Hong Kong. Asian Pac J Cancer Prev \n                           12, 2539 (2011).","journal-title":"Asian Pac J Cancer Prev"},{"key":"13299_CR9","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2014.15.17.7333","volume":"15","author":"XC Wang","year":"2014","unstructured":"Wang, X. C. et al. Prevalence and genotype distribution of human papillomavirus among women from Henan, China. Asian Pac J Cancer Prev \n                           15, 7333 (2014).","journal-title":"Asian Pac J Cancer Prev"},{"key":"13299_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24281","volume":"87","author":"Q Bi","year":"2015","unstructured":"Bi, Q. et al. Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China. J Med Virol\u00a087, 2114 (2015).","journal-title":"J Med Virol"},{"key":"13299_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep21039","volume":"6","author":"Z Li","year":"2016","unstructured":"Li, Z. et al. Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China. Sci Rep \n                           6, 21039 (2016).","journal-title":"Sci Rep"},{"key":"13299_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-014-0708-8","volume":"14","author":"XX Liu","year":"2014","unstructured":"Liu, X. X. et al. Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study. BMC Infect Dis \n                           14, 708 (2014).","journal-title":"BMC Infect Dis"},{"key":"13299_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw010","volume":"145","author":"Z Zeng","year":"2016","unstructured":"Zeng, Z. et al. Prevalence of High-Risk Human Papillomavirus Infection in China: Analysis of 671,163 Human Papillomavirus Test Results From China\u2019s Largest College of American Pathologists-Certified Laboratory. Am J Clin Pathol\u00a0145, 622 (2016).","journal-title":"Am J Clin Pathol"},{"key":"13299_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford, G. M. et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet\u00a0366, 991 (2005).","journal-title":"Lancet"},{"key":"13299_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-66","volume":"7","author":"L Jing","year":"2010","unstructured":"Jing, L. & Ye, J. et al. Prevalence and risk profile of cervical human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virol J \n                           7, 66 (2010).","journal-title":"Virol J"},{"key":"13299_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0998-5","volume":"15","author":"R Wang","year":"2015","unstructured":"Wang, R. et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis \n                           15, 257 (2015).","journal-title":"BMC Infect Dis"},{"key":"13299_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-388","volume":"14","author":"L Jing","year":"2014","unstructured":"Jing, L. et al. HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province, China: a cross-sectional study. BMC Infect Dis \n                           14, 388 (2014).","journal-title":"BMC Infect Dis"},{"key":"13299_CR18","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962011000200014","volume":"86","author":"M Leto","year":"2011","unstructured":"Leto, M., Santos, J. G., Porro, A. M. & Tomimori, J. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol\u00a086, 306 (2011).","journal-title":"An Bras Dermatol"},{"key":"13299_CR19","doi-asserted-by":"publisher","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni, L. et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis \n                           202, 1789 (2010).","journal-title":"J Infect Dis"},{"key":"13299_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(03)00312-4","volume":"198","author":"SA Lee","year":"2003","unstructured":"Lee, S. A. et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett \n                           198, 187 (2003).","journal-title":"Cancer Lett"},{"key":"13299_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00087-13","volume":"51","author":"M Schmitt","year":"2013","unstructured":"Schmitt, M. et al. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol\u00a051, 1458 (2013).","journal-title":"J Clin Microbiol"},{"key":"13299_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.06.018","volume":"134","author":"A Carrillo-Garcia","year":"2014","unstructured":"Carrillo-Garcia, A. et al. Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer. Gynecol Oncol\u00a0134, 534 (2014).","journal-title":"Gynecol Oncol"},{"key":"13299_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-013-0162-8","volume":"24","author":"EQ Wu","year":"2013","unstructured":"Wu, E. Q. et al. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes Control \n                           24, 795 (2013).","journal-title":"Cancer Causes Control"},{"key":"13299_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27608","volume":"132","author":"CM Wheeler","year":"2013","unstructured":"Wheeler, C. M. et al. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer\u00a0\n                           132, 198 (2013).","journal-title":"Int J Cancer"},{"key":"13299_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.11.005","volume":"415","author":"Y Shen","year":"2013","unstructured":"Shen, Y. et al. Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Henan Province, China. Clin Chim Acta \n                           415, 297 (2013).","journal-title":"Clin Chim Acta"},{"key":"13299_CR26","doi-asserted-by":"publisher","DOI":"10.1590\/SO100-720320140004995","volume":"36","author":"A Bruno","year":"2014","unstructured":"Bruno, A., Serravalle, K., Travassos, A. G. & Lima, B. G. [Genotype distribution of human papillomavirus in women from the state of Bahia, Brazil]. Rev Bras Ginecol Obstet \n                           36, 416 (2014).","journal-title":"Rev Bras Ginecol Obstet"},{"key":"13299_CR27","doi-asserted-by":"publisher","DOI":"10.1159\/000355099","volume":"57","author":"M de Jonge","year":"2013","unstructured":"de Jonge, M., Busecke, G., Heinecke, A. & Bettendorf, O. Human papillomavirus genotype distribution in cytologically screened women from northwest Germany. Acta Cytol\u00a057, 591 (2013).","journal-title":"Acta Cytol"},{"key":"13299_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon, D. et al. The2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA \n                           287, 2114 (2002).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13299-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:52:57Z","timestamp":1671799977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13299-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13299"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13299-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]},"assertion":[{"value":"9 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14813"}}